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Abstract 
Background: Dural fistula to the cavernous 
sinus (DFCS) is an infrequent pathology that 
consists in the anomalous communication 
between the meningeal branches of the 
internal carotid artery (ICA) and/or the 
external carotid artery (ECA) and the 
cavernous sinus. 
Aim: To perform a systematic review to 
evaluate clinical and imaging findings in 
DFCS, and current indications for treatment. 
Methods: A literature search was 
performed in several medical databases using 
the keywords “intracranial dural fistula”, 
“carotid-cavernous fistula”, “endovascular 
treatment”, associated with “outcome”; 
resulting articles were assessed by considering 
factors such as: number of patients treated, 
type of material used, complications, and type 
of image technique used for diagnosis. 
Results: 33 articles were selected, yielding: 
clinical and imaging: The symptoms are 
basically related to the type of venous drainage 
of the fistula. The combination of ocular 
symptoms and tinnitus is highly suggestive of 
DFCS. Ocular symptoms are found in 80-97% 
of patients, while the tinnitus is present in up 
to 50% of cases. The imaging method for initial 
assessment of the DFCS is the magnetic 
resonance imaging. Digital subtraction 
angiography is the method of choice to 
determine adequately the precise 
angioarchitecture of the injury and its 
drainage. This data is of vital importance in 
future decision making. Treatment: Currently 
are considered as indications for the 
management of DFCS: 1) rapidly progressive 
deterioration of visual function, 2) 
angiographic evidence of abnormal cortical 
venous drainage, 3) the hypoxic consequences 
in retina and optic nerve, and 4) ischemic 
keratitis; the most suitable materials for 
embolization of the DFCS are CA and PAP. 
Conclusion: DFCS stills being an 
uncommon cerebrovascular condition, with 
good outcomes from endovascular treatment. 
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Introduction 
Intracranial arteriovenous fistulae are of 
two main types: carotid-cavernous fistulas 
(CCF) and dural arteriovenous fistulas. CCF is 
an infrequent pathology that consists in the 
anomalous communication between the 
meningeal branches of the internal carotid 
artery (ICA) and/or the external carotid artery 
(ECA) and the cavernous sinus. These belong 
to the indirect CCF. Unlike direct CCF which 
are frequently evocated by trauma, (1–5) 
indirect CCF more commonly occur 
spontaneously, being rare the traumatic 
etiology. (5, 6) Clinical manifestations 
generally follow a less severe course than direct 
CCF, being the ophthalmological symptoms 
and the presence of superior drainage, the 
most relevant data, mainly for provide an 
adequate therapeutic approach. Currently the 
preferred management is the endovascular. In 
this article we present a systematic review 
about endovascular management of dural 
fistulas into the cavernous sinus. 
Methods 
A literature search was performed in 
several medical databases including PubMed, 
EMBASE, Scopus, and Google Scholar; 
without restrictions or filters with regard to 
language or year of publication; showing a 
total of 33 results using the keywords 
“intracranial dural fistula”, “carotid-cavernous 
fistula”, “endovascular treatment”, associated 
with “outcome”. Emphasis was given to the 
angiographic, imaging and hemodynamic 
characteristics found usually in dural fistulas 
to the cavernous sinus (DFCS); the resulting 
articles were assessed by considering factors 
such as: number of patients treated, type of 
material used, complications, and type of 
image technique used for diagnosis. 
Etiology 
Indirect CCF occurs typically and 
spontaneously in postmenopausal women, 
although they can occur also in other age 
groups as consequence of pregnancy, sinusitis 
or cavernous sinus thrombosis. (5–8). There is 
not a universal and convenient explanation 
regard its genesis, however, since Houser et al 
demonstrated that thrombosis of the lateral 
and sigmoid sinus precede the formation of 
dural fistulas, many authors implied the 
thrombosis of the cavernous sinus as the 
natural precursor of the DFCS, pushing away 
the theory proposed by Newton and Hoyt, 
who pointed out as cause, the 
microtraumatisms over the delicate vessels of 
the carotid siphon (7).  
Meyers et al (5), reported their 15 years’ 
experience in the management of 135 
consecutive patients with diagnosis of DFCS, 
being none of traumatic etiology. Therefore, 
the frank traumatic etiology of the DFCS is 
extremely rare. Berenstein et al (9) in 1986, 
reported 11 cases of arteriovenous fistulas, and 
mention one of DFCS of traumatic origin. 
Keltner et al (10) in 1987, described the case of 
traumatic indirect CCF within a total of 12 
cases of CCF. Higashida et al (11) in an 
extensive review of 213 traumatic CCF 
published in 1989, found 7 cases of indirect 
fistula to the cavernous sinus. Jacobson et al 
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(6), in 1996 reported two additional cases of 
traumatic indirect CCF. 
Notably, Jacobson and colleagues conclude 
that the recognition of traumatic origin allow 
an adequate choice of route and material to be 
used, we do not think that the traumatic 
history is a planning guide for management, 
we believe the choice of route and the material 
will be governed by the amount and type of 
tributaries that have the fistula, and venous 
drainage pattern, considerations that go far 
beyond agreement cited by other authors (6, 7, 
10, 12).  
Clinical and imaging findings 
Clinical findings 
The symptoms are basically related to the 
type of venous drainage of the fistula, 
therefore: 1) anterior drainage into the 
superior ophthalmic vein originate 
ophthalmic symptoms, for example, 
exophthalmos and chemosis; 2) 
posteroinferior drainage into the petrosal 
sinus, basilar plexus and pterygoid plexus will 
produce murmurs, and deficit of some cranial 
nerves; 3) subsequent drainage into the 
superior petrosal sinus originates murmur; 4) 
cortical reflux into the sphenoparietal sinus 
and upper middle cerebral vein may cause 
infarction and hemorrhage; and 5) deep 
drainage into the deep middle cerebral vein 
and the uncal vein can trigger hemorrhages 
(13).  
These symptoms affecting intracranial and 
extracranial structures can be grouped into 
four patterns (14): a) orbital including 
chemosis, proptosis, eyelid edema and 
periorbital pain, b) cavernous with ptosis, 
diplopia, anisocoria and ophthalmoplegia, c) 
ocular with decreased visual acuity or 
increased intraocular pressure (> 20 mmHg or 
interocular difference greater than 5 mmHg), 
severe eye pain, glaucoma, and retinal 
hemorrhage, and d) cerebral, including 
cerebral venous congestion in the basal 
ganglia, brain stem or cerebellum promoting 
presence of epilepsy and hemorrhage. 
The combination of ocular symptoms and 
tinnitus is highly suggestive of DFCS. Ocular 
symptoms are found in 80-97% of patients, 
while the tinnitus is present in up to 50% of 
cases. These symptoms are usually less 
dramatic than direct CCF, and rarely are life-
threatening. The flow of DFCS is usually much 
lower than the direct CCF, being the most 
important reason to present a less aggressive 
clinical spectrum, however there are reports of 
significant morbidity such as blindness and 
stroke (15,16). About 30 to 40% cases of 
indirect CCF present cerebral hemorrhage due 
to the rupture of dilated cerebral veins as a 
result of retrograde drainage. 
When DFCS is clinically suspected, the 
patient must be carefully examined for 
confirmatory signs. In the presence of an eye 
with engorged vessels, conjunctival erythema 
or proptosis is mandatory to auscultate the 
skull and facial bones searching for murmurs. 
Usually the affected eye is ipsilateral to the 
fistula, however there are cases of bilateral 
symptoms due to the commitment of both 
cavernous sinuses because communication 
between them through intercavernous sinuses. 
Imaging findings 
The imaging method for initial assessment 
of the DFCS is the magnetic resonance 
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imaging (MRI). The findings include: 1) 
increased volume of the cavernous sinus; 2) 
loss of the interface between the cavernous 
sinus and the intracavernous portion of the 
ICA, 3) dilation of the superior ophthalmic 
vein (17, 18). 
Digital subtraction angiography (DSA) is 
the method of choice to determine adequately 
the precise angioarchitecture of the injury and 
its drainage. This data is of vital importance in 
future decision making. Therefore, the 
angiographic evaluation must provide specific 
information regarding arterial tributaries, the 
precise site of shunt and the venous drainage 
pattern. In many cases this analysis can only be 
complete during the therapeutic phase. For 
this, it is recommended the angiographical 
evaluation in two phases: 1) diagnostic 
catheterization and 2) supraselective 
catheterization, which can be performed 
during treatment of the injury. 
Some authors have emphasized the 
importance of non-invasive alternatives 
modalities such as helical CT-angiography 
(angio-CT) and magnetic resonance 
angiography (MRA), which is supposed to 
characterize the injury angioarchitecture (18). 
However, even with the visualization of 
afferent vessels and draining veins, DSA only 
guides in analyzing how the different 
compartments involved are interrelated, and 
helps the understanding of the hemodynamics 
of the lesion, enabling better therapeutic 
approach. Thus, the DSA still remains the gold 
standard for assessing DFCS. 
Barrow et al (19) proposed an angiographic 
classification for CCF, revalidated by Debrun 
et al (7), and widely used by diverse authors, 
see Table 1. In the review of literature persists 
the trending of the predominance of the CCF 
type D over type C, being truly extraordinary 
the type B. 
TABLE 1 
Barrow classification of DFCS 
Type Fistulous vessels Characteristics 
A 
Carotid artery to cavernous 
sinus 
Direct, high 
flow, the most 
common 
B 
Dural ICA branches to 
Cavernous sinus: 
-Meningohypophyseal 
trunk (66%) 
-Inferolateral trunk (30%) 
Indirect, low 
flow 
C 
ECA branches to 
Cavernous sinus: 
-Internal maxillary (67%) 
-Middle meningeal (31%) 
-Ascending pharyngeal 
(24%) 
Indirect, low 
flow 
D 
Both ICA and ECA 
branches 
Indirect, the 
most common 
of low flow 
ICA: internal carotid artery; ECA: external carotid artery 
 
Why and when to treat DFCS? 
From all dural fistulas, about 10% to 60% 
can present spontaneous resolution, and 25 to 
50% are to the cavernous sinus, therefore have 
a much more benign course than direct CCF 
with a natural history that can lead to 
spontaneous healing. (10, 15, 16, 19–22) The 
cure occurring shortly after performing 
diagnostic angiography is not rare. Many 
patients experience a period of worsening of 
symptoms, particularly ophthalmics, during 
the spontaneous healing process. (12, 23) For 
this reason the decision on the management of 
the DFCS is controversial. Keltner, et al (10) 
treated by endovascular approach only 1 of the 
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10 cases reported, while 7 were offered only 
ophthalmologic management with treatment 
for glaucoma, reporting good control, 
therefore conclude that these cases should not 
be subjected to definitive treatment. 
Currently are considered as indications for 
the management of DFCS: 1) rapidly 
progressive deterioration of visual function, 2) 
angiographic evidence of abnormal cortical 
venous drainage, 3) the hypoxic consequences 
in retina and optic nerve, and 4) ischemic 
keratitis (5, 11, 12, 20). Among the 
mechanisms involved in the worsening of 
dural fistulas are: 1) stenosis or thrombosis of 
the outflow, 2) increasing of the arterial blood 
flow, and 3) the emergence of a new fistula or 
enlargement of preexisting shunt (21, 24). 
In the days before the advent of 
Neurological Endovascular Therapy, 
traditional surgery for the management of this 
condition was accompanied by a very high risk 
of thromboembolic events, almost always 
accompanied by cerebral ischemic disease 
and/or blindness (11). Currently the 
endovascular therapy is considered as the 
treatment of choice for all types of CCF for the 
following reasons: 1) is performed under local 
anesthesia with the possibility of ongoing 
clinical evaluation of the patient for early 
detection of any complication, 2) is a low risk 
approach, 3) less time consumption during the 
procedure, 4) reaches surgically inaccessible 
sites, 5) more likely to conserve the ICA blood 
flow, 6) fast recovery of the patient, and 7) 
there is always the possibility to repeat the 
procedure in case of initial failure or 
recurrence of the fistula (3–5, 7, 9, 11, 12, 20, 
25) 
Approach route 
The DFCS are arteriovenous or 
arteriovenous shunts, in these cases it is 
determined that occlusion of the venous 
portion is the treatment of choice (26–28) for 
this purpose transvenous route is usually the 
best access method for insertion and release of 
embolic material, with current predominant 
use of detachable coils. Different routes have 
been described and used to reach the 
cavernous sinus, such as through lower 
petrosal sinus (contralateral or ipsilateral), 
basilar plexus, circular or intercavernous 
sinus, through the facial vein, the angular and 
superior ophthalmic veins or through the 
pterygoid plexus (5, 11, 20, 24, 25, 29–34). 
In a large retrospective study, Mayers et al 
(5), summarizes 15 years of experience in the 
management of 135 DFCS patients treated 
transvenously, coils were used in 87% of cases, 
pieces of suture material in 13% and only in 3% 
of patients was used liquid adhesive material. 
They reported good long-term results in 97% 
of cases. Cheng et al (25) reported the cases of 
27 patients treated transvenously with GDC 
and fibered coils, where only one case was 
necessary to combine with the arterial line for 
administration of PAP; in these same study, 
89% of the cases experimented angiographic 
cure (25).  
Retrospectively, Klish et al, reported 11 
cases of DFCS embolized by transvenous 
approach with coils, reaching a frequency of 
anatomical cure of 63%, however, they refer 
that all patients, including those who did not 
achieve such healing, showed improvement in 
their symptoms (20). Reported complications 
of the transvenous approach with occlusion of 
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the cavernous sinus, the lesion of the vein 
access, the immediate and rapid increase of the 
ophthalmologic symptomatology and the 
injury of any of the oculomotor nerves caused 
either by over-packing of coils or induced 
thrombotic process itself within the sinus (10, 
25). Furthermore, it has been determined in 
the case of dural fistulas that sinus therapeutic 
occlusion with coils, and the subsequent 
thrombosis can activate angiogenic factors 
within the adjacent dural walls (22, 32, 35–37). 
In cases where it is not possible to exploit 
adequately the venous approach, the arterial 
approach can be useful (11, 12). CA is the 
material of choice in the arterial approach 
because allows better control of time and 
degree of polymerization modifying its 
dilution with the lipid contrast dye without 
starting with a total sacrifice of the circulation 
of the cavernous sinus, situation that makes it 
a more controllable material than PAP. 
Some authors not use the transvenous 
approach just for the likelihood of these 
complications plus it is expensive for the 
number of coils typically required to occlude 
the cavernous sinus, fact that in economic 
stringency environments becomes a major 
limiting factor in the decision making.  
One limitation of the arterial approach is 
the partial treatment of the fistula, particularly 
in type D cases, in which only were treated the 
fistulous pedicles of a single axis. This, in 
theory, perpetuates the fistula and may even 
increase the flow in other components, but our 
percentage of success and immediate and 
long-term cure is high. We think this is 
because the decision to embolize the pedicles 
of greater flow, and allow the passage of 
embolic material to the malformation own 
nest which could induce a progressive 
thrombosis of the compromised segments of 
the cavernous sinus, this thrombosis is seen 
further promoted by combination with 
manual compression maneuver of the carotid 
artery. Hence can be avoided the nerve 
damage of oculomotor nerves or 
ophthalmologic deterioration that can be 
observed with the venous approach, and is a 
far less expensive method.  
Satomi et al (24), have shown that partial 
treatment of DFCS, to what they have called 
palliative treatment, induces progressive 
changes in the pattern of venous drainage of 
the cavernous sinus with a trend towards very 
benign evolution with minimal 
ophthalmological commitment and almost no 
dilated cortical veins. 
Another advantage observed with the 
arterial approach is the use of catheters guided 
by the flow, so far as possible avoids the use of 
microguides, which are to blame for vascular 
injury in case of venous approach. Among the 
complications of trans-arterial route, Viñuela 
et al (12) reported migration of the CA into 
distal branches of the middle cerebral artery, 
fortunately without much clinical implication, 
in addition to the transient increase in retro-
ocular pain of one patient.  
Embolization material 
Viñuela et al (12) concluded that the most 
suitable materials for embolization of the 
DFCS are CA and PAP. The use of CA is 
currently widespread in the management of 
arteriovenous malformations (AVM), the 
opposite situation occurs in DFCS with few 
reports or small series. CA was first used as 
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management of direct CCF in a case treated by 
Bank et al (38) and in three cases managed by 
Kerber et al (39) reported in 1978 and 1979, 
respectively in which is highlighted the 
conservation of the carotid flow which was 
established in a situation really encouraging, in 
a time when most endovascular and surgical 
techniques aimed to blood flow occlusion of 
the ICA. 
It is noteworthy that the experience of the 
last authors was when acrylic was not 
approved by the FDA for use in humans in 
northamerica. So was criticized and 
considered dangerous, and that the three cases 
described by Kerber et al (39) presented some 
type of deficit arising from the migration of the 
substance or by the application of the 
microcatheter or the non-detachable ballon 
technique used to administrate the substance, 
although the deficit was transient and the 
evolution of the patients was good in the short 
and medium term. Some authors like Pierot et 
al (40), Luo et al (3) and Wang et al (41) 
reported their successful experience with CA 
in management of direct CCF of traumatic 
origin, partially treated or recurrent. 
Berenstein et al (9) were first to use CA in the 
management of DFCS, which in turn was 
caused by trauma (9). 
From 10 cases described by Keltner et al 
(10), only one was treated by endovascular 
technique with glue, precisely their single case 
secondary to trauma. Viñuela et al (12) 
described a series of 16 spontaneous DFCS, of 
which four were treated with AC, 1 with CA 
and surgery, 1 with CA and particles, and 3 
with only particles. From all cases only one was 
identified as "inadequate" healing. These 
authors conclude that the CA and the particles 
must be considered as the treatment of choice 
in the DFCS because allow superselective and 
more distal tributary vessels occlusion near the 
nest of the arterio-venous fistula, they consider 
that this may be sufficient to promote the 
cavernous sinus thrombosis with consequent 
total occlusion of the lesion. 
Debrun et al (7) reported 132 cases of CCF, 
from which 32 were DFCS, of which 13 cases 
were treated only with CA, and the remaining 
with PAP or a mixture of both. Cure was 
obtained in 16 patients, whereas in the patients 
without early cure, some progressively 
improved, while others were lost to follow. It is 
necessary to emphasize that in this study the 
majority of indirect fistulas were type D (28 of 
32 cases) and the authors conclude that they 
are the most difficult to treat because of the 
increased number of branches involved, which 
came from both ACE and ACI, hence adequate 
obliteration was more difficult to achieve, 
especially when considering that that 
occlusion of only ACE flow can result in 
increased participation of the meningeal 
branches of the ICA with much more difficult 
management in later stages (7). 
Type D fistulas are more laborious, also 
require more mental exercise and can be 
disappointing for the endovascular specialist. 
For this reason some authors have considered 
to radiosurgery as a treatment option in 
selected cases, being combined with 
embolization or even with no pretreatment 
(42–46), however, more experience is needed 
with long-term outcomes to determine its 
efficacy and safety. 
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Conclusions 
DFCS stills being an uncommon 
cerebrovascular condition, with good 
outcomes from endovascular treatment. 
Currently the endovascular therapy is 
considered as the treatment of choice for all 
types of CCF, because good outcomes, and 
because traditional surgery is accompanied by 
a very high risk of thromboembolic events, 
almost always accompanied by cerebral 
ischemic disease and/or blindness. 
 
Abbreviations: 
AVM: Arterio-venous malformation 
CA: Cyanoacrylate. 
CCF: Carotid-cavernous fistula. 
DFCS: Dural fistula into the cavernous sinus 
DSA: Digital substraction angiography 
ECA: External carotid artery. 
GDC: Guglielmi detachable coils. 
ICA: Internal carotid artery. 
MRI: Magnetic resonance imaging 
PAP: Polyvinyl-alcohol particles. 
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